Vakiener Victoria sold ARWR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001826263-25-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 19, 2025

Published

Dec 23, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

Vakiener Victoria

Role

Director

Transaction

Open-market saleAs filed: “S”

Asset

ARROWHEAD PHARMACEUTICALS, INC.

Ticker

ARWR

Shares

5,281

Price per share

$67.97

Value

$358,950

Execution date (reported)

Dec 19, 2025

Owned after transaction

37.7K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

4

Calculation

What this establishes

Vakiener Victoria filed this Form 4 reporting a open-market sale of ARWR on Dec 19, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Vakiener Victoriacik:0001826263

Issuer

ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407

Revision history · 0

No field has changed since this record was first ingested.